The Challenge Embraced by the Young Researchers Thriving at Veneno At Veneno Technologies, we are transforming nature’s venoms into breakthrough medicines. Armed with our proprietary platform, it is the passionate young researchers who are stepping into unexplored frontiers in biotechnology. Here, we take a closer look at the stage on which the next generation of […]

With more than a decade of experience in molecular microbiology and genetic engineering, Huong Minh Nguyen is pursuing the potential of disulfide-rich peptides (DRPs) at Veneno Technologies. What drives her is a simple yet powerful belief: that genuine curiosity can connect people across borders and disciplines. Here, we take a closer look at her philosophy […]

Hiroo Tanaka, who is translating deep academic expertise into real-world applications, and Takumi Okamoto, who is channeling the untapped potential of plants into innovation in agriculture. These two young researchers, each with a different area of specialization, are using Veneno Technologies’ platform as a powerful tool to push beyond conventional boundaries and open new frontiers […]

In the turbulent world of biotech startups, Veneno Technologies has carved out a distinctive position of its own. At the heart of that achievement lies Director and CTO Tadashi Kimura’s uncompromising devotion to technology, a commitment he has sustained over many years. Since the company’s founding, Kimura has remained at the forefront of its research, […]

“Transforming venom, one of nature’s most powerful bioactive substances, into hope for humanity.” That is the bold mission driving Veneno Technologies. Led by President and CEO Takatoshi Kuno, the company is working to break through the limitations of conventional drug discovery with its proprietary peptide engineering technologies. Together with partners around the world, Veneno is […]